Prasterone 10mg / Calcium carbonate 47mg tablets
Requires a prescription from a doctor or prescriber
Minimal controls; includes benzodiazepines and anabolic steroids
Legal requirements and restrictions
Anabolic steroids and related substances. Possession for personal use is not an offence, but supply is controlled.
Legal requirements
- Prescriptions valid for 28 days
- No controlled drugs register required
- No safe custody requirements
- Import/export restrictions apply
Other medicines in this category
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 30 studies.
Reviews & meta-analyses: 15 · 2019–2024
Showing all 30 studies, sorted by most relevant.
M. J. Castro-Alonso, L. E. Montañez-Hernández, M. Sánchez-Muñoz, et al.
Frontiers in Materials, 2019
In this review, microbiological and molecular concepts of Microbially induced Calcium Carbonate Precipitation (MICP) and their role in bioconcrete are discussed. MICP is a widespread biochemical process in soils, caves, freshwater, marine sediments and hypersaline habitats. MICP is an outcome of metabolic interactions between diverse microbial communities with organic and/or inorganic compounds present in environment. Some of the major metabolic processes involved in MICP at different levels are urea hydrolysis, denitrification, dissimilatory sulfate reduction and photosynthesis. Currently, MICP directed by urea hydrolysis, denitrification and dissimilatory sulfate reduction has been reported to aid in development of bioconcrete and demonstrated improvement in mechanical and structural properties of concrete. Bioconcrete is a promising sustainable technology in reducing the negative environmental impacts due to CO2 emission from construction sector and as well as in terms of economic benefits by way of promoting self-healing process of the concrete structures. Among the metabolic processes mentioned above, urea hydrolysis is the most applied in concrete repair mechanisms. MICP by urea hydrolysis is induced by a series of reactions driven by urease (Ur) and carbonic anhydrase (CA). Catalytic activity of these two enzymes depends on diverse parameters, which are currently being studied under laboratory conditions to understand the biochemical mechanisms involved and their regulation in microorganisms. It is clearly evident that microbiological and molecular components are essential to improve the process and performance of bioconcrete.
Abstract licence: CC BY
Yuanyuan Niu, Jia-Hui Liu, C. Aymonier, et al.
Chemical Society reviews, 2022
- Calcium Carbonate
- Nanocomposites
- Biocompatible Materials
Various new strategies have been recently developed to produce CaCO 3 micro-/nanoparticles with controlled size, morphology, polymorphism and crystallinity, which are then surface modified, functionalized and hierarchically assembled to yield medical, environmental, and energy materials.
Abstract licence: CC BY
Stephen Owuamanam, D. Cree
2020
Disposal of massive amounts of eggshells and seashells from processing industries is a challenge. In recent years, there has been a focus to reuse these waste resources in the production of new thermoplastic and thermoset polymer materials. This paper reviews eggshell and seashell production by country and provides a perspective on the quantity of bio-calcium carbonate that could be produced annually from these wastes. The achievements obtained from the addition of recycled bio-calcium carbonate fillers (uncoated/unmodified) in polymer composites with a focus on tensile strength, flexural strength and impact toughness are discussed. To improve compatibility between calcium carbonate (mineral and bio-based) fillers and polymers, studies on surface modifiers are reviewed. Knowledge gaps and future research and development thoughts are outlined. Developing novel and innovative composites for this waste material could bring additional revenue to egg and seafood processors and at the same time reduce any environmental impact.
Abstract licence: CC BY
S. C. Chuo, S. Mohamed, S. H. Mohd Setapar, et al.
Materials, 2020
Nowadays, microbially induced calcium carbonate precipitation (MICP) has received great attention for its potential in construction and geotechnical applications. This technique has been used in biocementation of sand, consolidation of soil, production of self-healing concrete or mortar, and removal of heavy metal ions from water. The products of MICP often have enhanced strength, durability, and self-healing ability. Utilization of the MICP technique can also increase sustainability, especially in the construction industry where a huge portion of the materials used is not sustainable. The presence of bacteria is essential for MICP to occur. Bacteria promote the conversion of suitable compounds into carbonate ions, change the microenvironment to favor precipitation of calcium carbonate, and act as precipitation sites for calcium carbonate crystals. Many bacteria have been discovered and tested for MICP potential. This paper reviews the bacteria used for MICP in some of the most recent studies. Bacteria that can cause MICP include ureolytic bacteria, non-ureolytic bacteria, cyanobacteria, nitrate reducing bacteria, and sulfate reducing bacteria. The most studied bacterium for MICP over the years is Sporosarcina pasteurii. Other bacteria from Bacillus species are also frequently investigated. Several factors that affect MICP performance are bacterial strain, bacterial concentration, nutrient concentration, calcium source concentration, addition of other substances, and methods to distribute bacteria. Several suggestions for future studies such as CO2 sequestration through MICP, cost reduction by using plant or animal wastes as media, and genetic modification of bacteria to enhance MICP have been put forward.
Abstract licence: CC BY
D. Trushina, T. Borodina, S. Belyakov, et al.
Materials Today. Advances, 2022
The recent successful application of lipid-based nanoparticles as delivery vehicles in COVID-19 vaccines demonstrated the superior potential of nanoparticle-based technology for targeted drug delivery in biomedicine. Among novel, rapidly advancing delivery platforms, the inorganic nano/microparticles gradually reach new heights and attract well-deserved attention among scientists and clinicians. Calcium carbonate in its vaterite form is used as a biocompatible carrier for a progressively increasing number of biomedical applications. Its growing popularity is conferred by beneficial porosity of particles, high mechanical stability, biodegradability under certain physiological conditions, ability to provide a continuous steady release of bioactives, preferential safety profile, and low cost, which make calcium carbonate a suitable entity of highly efficacious formulations for controlled drug delivery and release. The focal point of the current review is the success of the recent vaterite applications in the delivery of various diagnostics and therapeutic drugs. The manuscript highlights the nuances of drug loading in vaterite particles, connecting it with particle morphology, size, and charge of the loaded molecules, payload concentration, mono- or multiple drug loading. The manuscript also depicts recent successful methods of increasing the loading capacity developed for vaterite carriers. In addition, the review describes the various administration routes for vaterite particles with bioactive payloads, which were reported in recent years. Special attention is given to the multi-drug-loaded vaterite particles (“molecular cocktails”) and reports on their successful delivery in vitro and in vivo.
Abstract licence: CC BY-NC-ND
Kohobhange S. P. Karunadasa, C. Manoratne, H. Pitawala, et al.
Journal of Physics and Chemistry of Solids, 2019
C. Cornwall, S. Comeau, Niklas A. Kornder, et al.
Proceedings of the National Academy of Sciences of the United States of America, 2021
- Climate Change
- Coral Reefs
- Calcium Carbonate
Jun Feng, Bingcheng Chen, Weiwei Sun, et al.
Construction and Building Materials, 2021
Muhammad Naveed, J. Duan, S. Uddin, et al.
Ecological Engineering, 2020
Mengzhu Song, Tongyao Ju, Yuan Meng, et al.
Chemosphere, 2021
- Calcium Carbonate
- Soil
- Carbonates
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.